Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2014

Open Access 01-12-2014 | Research article

Endurance training or beta-blockade can partially block the energy metabolism remodeling taking place in experimental chronic left ventricle volume overload

Authors: Dominic Lachance, Wahiba Dhahri, Marie-Claude Drolet, Élise Roussel, Suzanne Gascon, Otman Sarrhini, Jacques A Rousseau, Roger Lecomte, Marie Arsenault, Jacques Couet

Published in: BMC Cardiovascular Disorders | Issue 1/2014

Login to get access

Abstract

Background

Patients with chronic aortic valve regurgitation (AR) causing left ventricular (LV) volume overload can remain asymptomatic for many years despite having a severely dilated heart. The sudden development of heart failure is not well understood but alterations of myocardial energy metabolism may be contributive. We studied the evolution of LV energy metabolism in experimental AR.

Methods

LV glucose utilization was evaluated in vivo by positron emission tomography (microPET) scanning of 6-month AR rats. Sham-operated or AR rats (n = 10-30 animals/group) were evaluated 3, 6 or 9 months post-surgery. We also tested treatment intervention in order to evaluate their impact on metabolism. AR rats (20 animals) were trained on a treadmill 5 times a week for 9 months and another group of rats received a beta-blockade treatment (carvedilol) for 6 months.

Results

MicroPET revealed an abnormal increase in glucose consumption in the LV free wall of AR rats at 6 months. On the other hand, fatty acid beta-oxidation was significantly reduced compared to sham control rats 6 months post AR induction. A significant decrease in citrate synthase and complex 1 activity suggested that mitochondrial oxidative phosphorylation was also affected maybe as soon as 3 months post-AR.
Moderate intensity endurance training starting 2 weeks post-AR was able to partially normalize the activity of various myocardial enzymes implicated in energy metabolism. The same was true for the AR rats treated with carvedilol (30 mg/kg/d). Responses to these interventions were different at the level of gene expression. We measured mRNA levels of a number of genes implicated in the transport of energy substrates and we observed that training did not reverse the general down-regulation of these genes in AR rats whereas carvedilol normalized the expression of most of them.

Conclusion

This study shows that myocardial energy metabolism remodeling taking place in the dilated left ventricle submitted to severe volume overload from AR can be partially avoided by exercise or beta-blockade in rats.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Ingwall JS: On substrate selection for ATP synthesis in the failing human myocardium. Am J Physiol Heart Circ Physiol. 2007, 293: H3225-H3226. 10.1152/ajpheart.01119.2007.CrossRefPubMed Ingwall JS: On substrate selection for ATP synthesis in the failing human myocardium. Am J Physiol Heart Circ Physiol. 2007, 293: H3225-H3226. 10.1152/ajpheart.01119.2007.CrossRefPubMed
3.
go back to reference Allard MF, Wambolt RB, Longnus SL, Grist M, Lydell CP, Parsons HL, Rodrigues B, Hall JL, Stanley WC, Bondy GP: Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol Endocrinol Metab. 2000, 279: E487-E493.PubMed Allard MF, Wambolt RB, Longnus SL, Grist M, Lydell CP, Parsons HL, Rodrigues B, Hall JL, Stanley WC, Bondy GP: Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol Endocrinol Metab. 2000, 279: E487-E493.PubMed
4.
go back to reference Hasegawa S, Yamamoto K, Sakata Y, Takeda Y, Kajimoto K, Kanai Y, Hori M, Hatazawa J: Effects of cardiac energy efficiency in diastolic heart failure: assessment with positron emission tomography with 11C-acetate. Hypertens Res. 2008, 31: 1157-1162. 10.1291/hypres.31.1157.CrossRefPubMed Hasegawa S, Yamamoto K, Sakata Y, Takeda Y, Kajimoto K, Kanai Y, Hori M, Hatazawa J: Effects of cardiac energy efficiency in diastolic heart failure: assessment with positron emission tomography with 11C-acetate. Hypertens Res. 2008, 31: 1157-1162. 10.1291/hypres.31.1157.CrossRefPubMed
5.
go back to reference Bittl JA, Ingwall JS: The energetics of myocardial stretch. Creatine kinase flux and oxygen consumption in the noncontracting rat heart. Circ Res. 1986, 58: 378-383. 10.1161/01.RES.58.3.378.CrossRefPubMed Bittl JA, Ingwall JS: The energetics of myocardial stretch. Creatine kinase flux and oxygen consumption in the noncontracting rat heart. Circ Res. 1986, 58: 378-383. 10.1161/01.RES.58.3.378.CrossRefPubMed
6.
go back to reference Pouleur H: Diastolic dysfunction and myocardial energetics. Eur Heart J. 1990, 11 (Suppl C): 30-34. 10.1093/eurheartj/11.suppl_C.30.CrossRefPubMed Pouleur H: Diastolic dysfunction and myocardial energetics. Eur Heart J. 1990, 11 (Suppl C): 30-34. 10.1093/eurheartj/11.suppl_C.30.CrossRefPubMed
7.
go back to reference Zhang J: Myocardial energetics in cardiac hypertrophy. Clin Exp Pharmacol Physiol. 2002, 29: 351-359. 10.1046/j.1440-1681.2002.03657.x.CrossRefPubMed Zhang J: Myocardial energetics in cardiac hypertrophy. Clin Exp Pharmacol Physiol. 2002, 29: 351-359. 10.1046/j.1440-1681.2002.03657.x.CrossRefPubMed
8.
go back to reference Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP: Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996, 94: 2837-2842. 10.1161/01.CIR.94.11.2837.CrossRefPubMed Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP: Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996, 94: 2837-2842. 10.1161/01.CIR.94.11.2837.CrossRefPubMed
9.
go back to reference Alaoui-Talibi Z, Guendouz A, Moravec M, Moravec J: Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine. Am J Physiol. 1997, 272: H1615-H1624.PubMed Alaoui-Talibi Z, Guendouz A, Moravec M, Moravec J: Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine. Am J Physiol. 1997, 272: H1615-H1624.PubMed
10.
go back to reference Alaoui-Talibi Z, Landormy S, Loireau A, Moravec J: Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Physiol. 1992, 262: H1068-H1074.PubMed Alaoui-Talibi Z, Landormy S, Loireau A, Moravec J: Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Physiol. 1992, 262: H1068-H1074.PubMed
11.
go back to reference Christian B, Alaoui-Talibi Z, Moravec M, Moravec J: Palmitate oxidation by the mitochondria from volume-overloaded rat hearts. Mol Cell Biochem. 1998, 180: 117-128. 10.1023/A:1006851325669.CrossRefPubMed Christian B, Alaoui-Talibi Z, Moravec M, Moravec J: Palmitate oxidation by the mitochondria from volume-overloaded rat hearts. Mol Cell Biochem. 1998, 180: 117-128. 10.1023/A:1006851325669.CrossRefPubMed
12.
go back to reference Field ML, Thompson C, Henderson C, Seymour AM, Radda GK: Changes in the myocardial creatine kinase isozyme profile with progression and regression of volume overload eccentric hypertrophy. Biochem Soc Trans. 1992, 20: 172S-CrossRefPubMed Field ML, Thompson C, Henderson C, Seymour AM, Radda GK: Changes in the myocardial creatine kinase isozyme profile with progression and regression of volume overload eccentric hypertrophy. Biochem Soc Trans. 1992, 20: 172S-CrossRefPubMed
13.
go back to reference Gibbs CL, Wendt IR, Kotsanas G, Young IR: Mechanical, energetic, and biochemical changes in long-term volume overload of rabbit heart. Am J Physiol. 1992, 262: H819-H827.PubMed Gibbs CL, Wendt IR, Kotsanas G, Young IR: Mechanical, energetic, and biochemical changes in long-term volume overload of rabbit heart. Am J Physiol. 1992, 262: H819-H827.PubMed
14.
go back to reference Janati-Idrissi R, Besson B, Laplace M, Bui MH: In situ mitochondrial function in volume overload- and pressure overload-induced cardiac hypertrophy in rats. Basic Res Cardiol. 1995, 90: 305-313. 10.1007/BF00797908.CrossRefPubMed Janati-Idrissi R, Besson B, Laplace M, Bui MH: In situ mitochondrial function in volume overload- and pressure overload-induced cardiac hypertrophy in rats. Basic Res Cardiol. 1995, 90: 305-313. 10.1007/BF00797908.CrossRefPubMed
15.
go back to reference Kiriazis H, Gibbs CL, Kotsanas G, Young IR: Mechanical and energetic changes in short-term volume and pressure overload of rabbit heart. Heart Vessels. 1992, 7: 175-188. 10.1007/BF01744602.CrossRefPubMed Kiriazis H, Gibbs CL, Kotsanas G, Young IR: Mechanical and energetic changes in short-term volume and pressure overload of rabbit heart. Heart Vessels. 1992, 7: 175-188. 10.1007/BF01744602.CrossRefPubMed
16.
go back to reference Marcil M, Ascah A, Matas J, Belanger S, Deschepper CF, Burelle Y: Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress. J Mol Cell Cardiol. 2006, 41: 998-1009. 10.1016/j.yjmcc.2006.08.117.CrossRefPubMed Marcil M, Ascah A, Matas J, Belanger S, Deschepper CF, Burelle Y: Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress. J Mol Cell Cardiol. 2006, 41: 998-1009. 10.1016/j.yjmcc.2006.08.117.CrossRefPubMed
17.
go back to reference Piper C, Horstkotte D, Bock AK, Wudel E, Schultheiss HP, Dorner A: Myocardial lactate dehydrogenase patterns in volume or pressure overloaded left ventricles. Eur J Heart Fail. 2002, 4: 587-591. 10.1016/S1388-9842(02)00088-0.CrossRefPubMed Piper C, Horstkotte D, Bock AK, Wudel E, Schultheiss HP, Dorner A: Myocardial lactate dehydrogenase patterns in volume or pressure overloaded left ventricles. Eur J Heart Fail. 2002, 4: 587-591. 10.1016/S1388-9842(02)00088-0.CrossRefPubMed
18.
go back to reference Schultz D, Su X, Bishop SP, Billadello J, Dell’Italia LJ: Selective induction of the creatine kinase-B gene in chronic volume overload hypertrophy is not affected by ACE-inhibitor therapy. J Mol Cell Cardiol. 1997, 29: 2665-2673. 10.1006/jmcc.1997.0498.CrossRefPubMed Schultz D, Su X, Bishop SP, Billadello J, Dell’Italia LJ: Selective induction of the creatine kinase-B gene in chronic volume overload hypertrophy is not affected by ACE-inhibitor therapy. J Mol Cell Cardiol. 1997, 29: 2665-2673. 10.1006/jmcc.1997.0498.CrossRefPubMed
19.
go back to reference Zhang J, Toher C, Erhard M, Zhang Y, Ugurbil K, Bache RJ, Lange T, Homans DC: Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy. Circulation. 1997, 96: 334-343. 10.1161/01.CIR.96.1.334.CrossRefPubMed Zhang J, Toher C, Erhard M, Zhang Y, Ugurbil K, Bache RJ, Lange T, Homans DC: Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy. Circulation. 1997, 96: 334-343. 10.1161/01.CIR.96.1.334.CrossRefPubMed
20.
go back to reference Bonow RO, Lakatos E, Maron BJ, Epstein SE: Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991, 84: 1625-1635. 10.1161/01.CIR.84.4.1625.CrossRefPubMed Bonow RO, Lakatos E, Maron BJ, Epstein SE: Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991, 84: 1625-1635. 10.1161/01.CIR.84.4.1625.CrossRefPubMed
21.
go back to reference Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006, 114: e84-e231. 10.1161/CIRCULATIONAHA.106.176857.CrossRefPubMed Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006, 114: e84-e231. 10.1161/CIRCULATIONAHA.106.176857.CrossRefPubMed
22.
go back to reference Plante E, Lachance D, Beaudoin J, Champetier S, Roussel E, Arsenault M, Couet J: Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation. Circ Heart Fail. 2009, 2: 25-32. 10.1161/CIRCHEARTFAILURE.108.801548.CrossRefPubMed Plante E, Lachance D, Beaudoin J, Champetier S, Roussel E, Arsenault M, Couet J: Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation. Circ Heart Fail. 2009, 2: 25-32. 10.1161/CIRCHEARTFAILURE.108.801548.CrossRefPubMed
23.
go back to reference Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M: Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation. Circ Heart Fail. 2011, 4: 207-213. 10.1161/CIRCHEARTFAILURE.110.958512.CrossRefPubMed Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M: Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation. Circ Heart Fail. 2011, 4: 207-213. 10.1161/CIRCHEARTFAILURE.110.958512.CrossRefPubMed
24.
go back to reference Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M: Usefulness of spironolactone in the treatment of chronic aortic valve regurgitation. J Heart Valve Dis. 2012, 21: 478-486.PubMed Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M: Usefulness of spironolactone in the treatment of chronic aortic valve regurgitation. J Heart Valve Dis. 2012, 21: 478-486.PubMed
25.
go back to reference Arsenault M, Zendaoui A, Roussel E, Drolet MC, Dhahri W, Grenier A, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J: Angiotensin II converting enzyme inhibition improves survival, ventricular remodeling and myocardial energetics in experimental aortic regurgitation. Circ Heart Fail. 2013, 6: 1021-1028. 10.1161/CIRCHEARTFAILURE.112.000045.CrossRefPubMed Arsenault M, Zendaoui A, Roussel E, Drolet MC, Dhahri W, Grenier A, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J: Angiotensin II converting enzyme inhibition improves survival, ventricular remodeling and myocardial energetics in experimental aortic regurgitation. Circ Heart Fail. 2013, 6: 1021-1028. 10.1161/CIRCHEARTFAILURE.112.000045.CrossRefPubMed
26.
go back to reference Lachance D, Plante E, Bouchard-Thomassin AA, Champetier S, Roussel E, Drolet MC, Arsenault M, Couet J: Moderate exercise training improves survival and ventricular remodeling in an animal model of left ventricular volume overload. Circ Heart Fail. 2009, 2: 437-445. 10.1161/CIRCHEARTFAILURE.108.845487.CrossRefPubMed Lachance D, Plante E, Bouchard-Thomassin AA, Champetier S, Roussel E, Drolet MC, Arsenault M, Couet J: Moderate exercise training improves survival and ventricular remodeling in an animal model of left ventricular volume overload. Circ Heart Fail. 2009, 2: 437-445. 10.1161/CIRCHEARTFAILURE.108.845487.CrossRefPubMed
27.
go back to reference Dhahri W, Roussel E, Drolet MC, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J, Arsenault M: Metformin reduces left ventricular eccentric re-modeling in experimental volume overload in the rat. J Clin Exp Cardiol. 2012, 13: 8- Dhahri W, Roussel E, Drolet MC, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J, Arsenault M: Metformin reduces left ventricular eccentric re-modeling in experimental volume overload in the rat. J Clin Exp Cardiol. 2012, 13: 8-
28.
go back to reference Arsenault M, Plante E, Drolet MC, Couet J: Experimental aortic regurgitation in rats under echocardiographic guidance. J Heart Valve Dis. 2002, 11: 128-134.PubMed Arsenault M, Plante E, Drolet MC, Couet J: Experimental aortic regurgitation in rats under echocardiographic guidance. J Heart Valve Dis. 2002, 11: 128-134.PubMed
29.
go back to reference Ménard SL, Ci X, Frisch F, Normand-Lauzière F, Cadorette J, Ouellet R, Van Lier JE, Bénard F, Bentourkia M, Lecomte R, Carpentier AC: Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats. Mol Imaging Biol. 2009, 11: 6-14. 10.1007/s11307-008-0171-2.CrossRefPubMed Ménard SL, Ci X, Frisch F, Normand-Lauzière F, Cadorette J, Ouellet R, Van Lier JE, Bénard F, Bentourkia M, Lecomte R, Carpentier AC: Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats. Mol Imaging Biol. 2009, 11: 6-14. 10.1007/s11307-008-0171-2.CrossRefPubMed
30.
go back to reference Ménard SL, Croteau E, Sarrhini O, Gélinas R, Brassard P, Ouellet R, Bentourkia M, van Lier JE, Des Rosiers C, Lecomte R, Carpentier AC: Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. Am J Physiol Endocrinol Metab. 2010, 298: E1049-E1057. 10.1152/ajpendo.00560.2009.CrossRefPubMed Ménard SL, Croteau E, Sarrhini O, Gélinas R, Brassard P, Ouellet R, Bentourkia M, van Lier JE, Des Rosiers C, Lecomte R, Carpentier AC: Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. Am J Physiol Endocrinol Metab. 2010, 298: E1049-E1057. 10.1152/ajpendo.00560.2009.CrossRefPubMed
31.
go back to reference Croteau E, Bénard F, Cadorette J, Gauthier ME, Aliaga A, Bentourkia M, Lecomte R: Quantitative gated PET for the assessment of left ventricular function in small animals. J Nucl Med. 2003, 44: 1655-1661.PubMed Croteau E, Bénard F, Cadorette J, Gauthier ME, Aliaga A, Bentourkia M, Lecomte R: Quantitative gated PET for the assessment of left ventricular function in small animals. J Nucl Med. 2003, 44: 1655-1661.PubMed
32.
go back to reference Croteau E, Gascon S, Bentourkia M, Langlois R, Rousseau JA, Lecomte R, Bénard F: [11C]Acetate rest–stress protocol to assess myocardial perfusion and oxygen consumption reserve in a model of congestive heart failure in rats. Nucl Med Biol. 2012, 39: 287-294. 10.1016/j.nucmedbio.2011.07.010.CrossRefPubMed Croteau E, Gascon S, Bentourkia M, Langlois R, Rousseau JA, Lecomte R, Bénard F: [11C]Acetate rest–stress protocol to assess myocardial perfusion and oxygen consumption reserve in a model of congestive heart failure in rats. Nucl Med Biol. 2012, 39: 287-294. 10.1016/j.nucmedbio.2011.07.010.CrossRefPubMed
33.
go back to reference Champetier S, Bojmehrani A, Beaudoin J, Lachance D, Plante E, Roussel E, Couet J, Arsenault M: Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems. Am J Physiol Heart Circ Physiol. 2009, 296: H669-H677. 10.1152/ajpheart.01046.2008.CrossRefPubMed Champetier S, Bojmehrani A, Beaudoin J, Lachance D, Plante E, Roussel E, Couet J, Arsenault M: Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems. Am J Physiol Heart Circ Physiol. 2009, 296: H669-H677. 10.1152/ajpheart.01046.2008.CrossRefPubMed
34.
go back to reference Bouchard-Thomassin AA, Lachance D, Drolet MC, Couet J, Arsenault M: A high fructose diet worsens eccentric left ventricular hypertrophy in experimental volume overload. Am J Physiol Heart Circ Physiol. 2011, 300: H125-H134. 10.1152/ajpheart.00199.2010.CrossRefPubMed Bouchard-Thomassin AA, Lachance D, Drolet MC, Couet J, Arsenault M: A high fructose diet worsens eccentric left ventricular hypertrophy in experimental volume overload. Am J Physiol Heart Circ Physiol. 2011, 300: H125-H134. 10.1152/ajpheart.00199.2010.CrossRefPubMed
35.
go back to reference Taha M, Lopaschuk GD: Alterations in energy metabolism in cardiomyopathies. Ann Med. 2007, 39: 594-607. 10.1080/07853890701618305.CrossRefPubMed Taha M, Lopaschuk GD: Alterations in energy metabolism in cardiomyopathies. Ann Med. 2007, 39: 594-607. 10.1080/07853890701618305.CrossRefPubMed
36.
go back to reference Plante E, Lachance D, Champetier S, Drolet MC, Roussel E, Arsenault M, Couet J: Benefits of long-term {beta}-blockade in experimental chronic aortic regurgitation. Am J Physiol Heart Circ Physiol. 2008, 294: H1888-H1895. 10.1152/ajpheart.01286.2007.CrossRefPubMed Plante E, Lachance D, Champetier S, Drolet MC, Roussel E, Arsenault M, Couet J: Benefits of long-term {beta}-blockade in experimental chronic aortic regurgitation. Am J Physiol Heart Circ Physiol. 2008, 294: H1888-H1895. 10.1152/ajpheart.01286.2007.CrossRefPubMed
37.
go back to reference Lachance D, Champetier S, Plante E, Bouchard-Thomassin AA, Roussel E, Couet J, Arsenault M: Effects of exercise in volume overload: insights from a model of aortic regurgitation. Med Sci Sports Exerc. 2009, 41: 1230-1238. 10.1249/MSS.0b013e318195b938.CrossRefPubMed Lachance D, Champetier S, Plante E, Bouchard-Thomassin AA, Roussel E, Couet J, Arsenault M: Effects of exercise in volume overload: insights from a model of aortic regurgitation. Med Sci Sports Exerc. 2009, 41: 1230-1238. 10.1249/MSS.0b013e318195b938.CrossRefPubMed
38.
go back to reference Buttrick P, Malhotra A, Factor S, Greenen D, Leinwand L, Scheuer J: Effect of aging and hypertension on myosin biochemistry and gene expression in the rat heart. Circ Res. 1991, 68: 645-652. 10.1161/01.RES.68.3.645.CrossRefPubMed Buttrick P, Malhotra A, Factor S, Greenen D, Leinwand L, Scheuer J: Effect of aging and hypertension on myosin biochemistry and gene expression in the rat heart. Circ Res. 1991, 68: 645-652. 10.1161/01.RES.68.3.645.CrossRefPubMed
39.
go back to reference Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF: Energy metabolism in the hypertrophied heart. Heart Fail Rev. 2002, 7: 161-173. 10.1023/A:1015380609464.CrossRefPubMed Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF: Energy metabolism in the hypertrophied heart. Heart Fail Rev. 2002, 7: 161-173. 10.1023/A:1015380609464.CrossRefPubMed
40.
go back to reference Brinkmann JF, Abumrad NA, Ibrahimi A, van der Vusse GJ, Glatz JF: New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem J. 2002, 367: 561-570. 10.1042/BJ20020747.CrossRefPubMedPubMedCentral Brinkmann JF, Abumrad NA, Ibrahimi A, van der Vusse GJ, Glatz JF: New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem J. 2002, 367: 561-570. 10.1042/BJ20020747.CrossRefPubMedPubMedCentral
41.
go back to reference Dorner A, Schultheiss HP: Adenine nucleotide translocase in the focus of cardiovascular diseases. Trends Cardiovasc Med. 2007, 17: 284-290. 10.1016/j.tcm.2007.10.001.CrossRefPubMed Dorner A, Schultheiss HP: Adenine nucleotide translocase in the focus of cardiovascular diseases. Trends Cardiovasc Med. 2007, 17: 284-290. 10.1016/j.tcm.2007.10.001.CrossRefPubMed
42.
go back to reference McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL: Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 2007, 104: 612-617. 10.1073/pnas.0606663104.CrossRefPubMedPubMedCentral McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL: Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 2007, 104: 612-617. 10.1073/pnas.0606663104.CrossRefPubMedPubMedCentral
43.
go back to reference Miyamoto S, Murphy AN, Brown JH: Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. J Bioenerg Biomembr. 2009, 41: 169-180. 10.1007/s10863-009-9205-y.CrossRefPubMedPubMedCentral Miyamoto S, Murphy AN, Brown JH: Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. J Bioenerg Biomembr. 2009, 41: 169-180. 10.1007/s10863-009-9205-y.CrossRefPubMedPubMedCentral
Metadata
Title
Endurance training or beta-blockade can partially block the energy metabolism remodeling taking place in experimental chronic left ventricle volume overload
Authors
Dominic Lachance
Wahiba Dhahri
Marie-Claude Drolet
Élise Roussel
Suzanne Gascon
Otman Sarrhini
Jacques A Rousseau
Roger Lecomte
Marie Arsenault
Jacques Couet
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2014
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-14-190

Other articles of this Issue 1/2014

BMC Cardiovascular Disorders 1/2014 Go to the issue